SCHEMBL17463187

SCHEMBL17463187

c1ccc(-c2cc(-c3ccccc3)nc([Si](c3ccccc3)(c3ccccc3)c3ccc4c(c3)c3ccccc3n4-c3ccccc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.45
KDM4E B2RXH2 3/20 0.45
ATM Q13315 2/20 0.45
KMT2A Q03164 5/20 0.34
TDP1 Q9NUW8 2/20 0.34
IL1R1 P14778 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 4/20 0.33
MAPT P10636 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
PTGER4 P35408 1/20 0.33
ACHE P22303 1/20 0.33
TSHR P16473 3/20 0.32
LMNA P02545 2/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17463191 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATDP1
SCHEMBL17463179 0.88 KDM4E (0.41) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17463195 0.88 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL26226699 0.86 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2ATDP1
SCHEMBL17463186 0.84 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2ATDP1
SCHEMBL17463196 0.84 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2ATDP1
SCHEMBL17461055 0.84 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL19044681 0.84 L3MBTL1 (0.60) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL22665491 0.84 L3MBTL1 (0.60) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17463201 0.84 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNE1 L3MBTL1 863/4885KDM4E 1882/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.